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Abstract
Venovenous extracorporeal membrane oxygenation (vv-ECMO) has been classically employed as a rescue therapy
for patients with respiratory failure not treatable with conventional mechanical ventilation alone. In recent years,
however, the timing of ECMO initiation has been readdressed and ECMO is often started earlier in the time course
of respiratory failure. Furthermore, some centers are starting to use ECMO as a first line of treatment, i.e., as an
alternative to invasive mechanical ventilation in awake, non-intubated, spontaneously breathing patients with
respiratory failure (“awake” ECMO). There is a strong rationale for this type of respiratory support as it avoids several
side effects related to sedation, intubation, and mechanical ventilation. However, the complexity of the patient–ECMO
interactions, the difficulties related to respiratory monitoring, and the management of an awake patient on
extracorporeal support together pose a major challenge for the intensive care unit staff. Here, we review the
use of vv-ECMO in awake, spontaneously breathing patients with respiratory failure, highlighting the pros and
cons of this approach, analyzing the pathophysiology of patient–ECMO interactions, detailing some of the
technical aspects, and summarizing the initial clinical experience gained over the past years.
Background
Venovenous extracorporeal membrane oxygenation
(vv-ECMO) has been classically employed as a rescue
therapy for patients with respiratory failure not treat-
able with conventional mechanical ventilation alone
[1, 2]. In recent years, however, ECMO is often started
earlier in the time course of the acute respiratory distress
syndrome (ARDS) in order to avoid possible detrimental
effects of mechanical ventilation, such as ventilator-
induced lung injury [3–5]. It might be of interest to under-
line that, in the mechanically ventilated patient on ECMO,
two lungs are contributing to respiration: the membrane
lung, which is extremely efficient, and the native, failing
lung, which can contribute only partially to gas exchange.
For this reason, some centers are pursuing the idea of
using ECMO as a first line treatment, i.e., as an alternative
to invasive mechanical ventilation in awake, non-intubated,
spontaneously breathing patients with respiratory failure
(“awake” ECMO). On one hand, this type of approach has
several advantages as it could avoid mechanical ventilation-
associated side effects; on the other, of course, its applica-
tion is associated with several challenges.
In the present review we summarize the current know-
ledge on and initial experience with the use of vv-ECMO
in awake, spontaneously breathing patients with respira-
tory failure.
Pros and cons of spontaneous breathing
Breathing is an active task in any surface-living animal
with lungs and in all marine mammals. “Spontaneous”
was an unnecessary adjective to the word “breathing”
until the era of mechanical ventilation began. Since then,
controversies have arisen regarding the advantages and
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disadvantages of maintaining spontaneous breathing in
critically ill patients with respiratory failure [6, 7], whose
treatment mainstay is still invasive mechanical ventilation.
In this section we summarize the possible advantages
(pros) and disadvantages (cons) of spontaneous breathing.
Pros
1. Spontaneously breathing patients preferentially move
the dorsal, more compliant part of their diaphragm.
Ventilation is therefore directed towards the most
dependent and better perfused parts of the lung,
leading to optimal ventilation–perfusion matching
[7]. In contrast, the shape of the diaphragm
is altered in the sedated, paralyzed, mechanically
ventilated patient [8], leading to a preferential
passive movement of the paralyzed diaphragm and
ventilation of the non-dependent lung. This worsens
ventilation–perfusion matching during mechanical
ventilation (Fig. 1).
2. The tone of the respiratory muscles in the awake,
spontaneously breathing subject guarantees the
expansion of the chest wall and lungs at end
expiration (functional residual capacity). In contrast,
anesthesia (with or without paralysis) leads to loss of
muscle tone, inward displacement of the ribcage [9],
and decreased functional residual capacity [10],
which, in turn, can favor the formation of atelectasis.
Of note, this mechanism is more pronounced in
edematous, “heavy”, ARDS lungs [11].
3. Maintaining diaphragmatic contraction and avoiding
controlled mechanical ventilation could prevent
ventilator-induced diaphragm dysfunction [12].
4. During spontaneous breathing, air moves from the
mouth to the alveoli through a decrease in
intrathoracic pressure, which favors venous return
from extra-thoracic organs, maintaining cardiac filling
and output. The same mechanism seems implicated
in favoring pulmonary lymphatic drainage [13]. On
the other hand, with mechanical ventilation the intra-
thoracic pressure increases during inspiration, having
the opposite effect of reducing venous return, cardiac
output, and thoracic lymph flow [13, 14].
5. The avoidance of endotracheal intubation could
reduce the incidence of ventilator/intubation-
associated pneumonia through the maintenance of
the natural barrier defenses against bacteria [15].
Cons
1. Transpulmonary pressure is one of the forces
implicated in the development of ventilator-induced
Fig. 1 Diaphragm motion and ventilation/perfusion distribution in the awake and in the anesthetized subject. The lung ventilation-to-perfusion
ratio (V/Q) is color-coded from white (high V/Q), to green (V/Q ≈ 1), to red (low V/Q). Diaphragm shape at end expiration (continuous line) and end
inspiration (dashed line) in the supine position is shown. Intra-abdominal pressure increases in the ventro-dorsal direction due to gravity (blue arrows)
and displaces the dorsal part of the diaphragm more cephalad than the ventral part at end expiration. During mechanical ventilation the pressure
applied by the mechanical ventilator displaces the ventral part of the diaphragm, which faces less intra-abdominal pressure, more than the dorsal part
(passive movement). Ventilation will thus be distributed preferentially to the ventral lung regions, increasing the ventilation-to-perfusion ratio (V/Q) of
these areas. In contrast, dorsal lung regions will receive less ventilation and their V/Q will be lower (a). During spontaneous breathing (either assisted
or unassisted), both the ventral and the dorsal part of the diaphragm move (active contraction). Ventilation will distribute more homogeneously along
the ventro-dorsal axis of the lung and will more closely match perfusion (V/Q ≈ 1) (b)
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lung injury [16–18]. Spontaneous breathing gener-
ates positive transpulmonary pressure (airway pres-
sure minus pleural pressure) similarly to mechanical
ventilation. Lung damage might therefore also derive
from spontaneous hyperventilation (spontaneous
ventilation-induced lung injury) [19–22].
2. When the work of breathing is very high, the
strenuous respiratory muscle effort can lead to high
oxygen (O2) consumption (and carbon dioxide
(CO2) production), i.e., a high cost of breathing,
which in turn could worsen hypoxemia. If gas
exchange needs are not met in other ways (e.g.,
through extracorporeal respiratory support),
sedation, intubation, and mechanical ventilation
could be necessary to avoid muscle exhaustion.
3. Emergent intubation and initiation of mechanical
ventilation might become necessary in the awake,
spontaneously breathing, non-intubated patient in
cases of ECMO equipment failure.
Pros and cons of keeping patients awake
Managing awake patients is a relatively new and challen-
ging task in medical intensive care units (ICU).
Pros
1. Reduction of delirium: the pathogenesis of delirium
in the ICU is multifactorial, one of the main
determinants being the use of sedative drugs [23].
Avoiding or reducing the amount of hypnotic agents
could therefore reduce the development of this
disturbance, which is associated with prolonged
ICU/hospital stay and mortality [24].
2. Rehabilitation: muscle mass loss and critical illness
myopathy and polyneuropathy often affect ICU
patients [25]. Awake patients can actively collaborate
with physiotherapists to perform physical
rehabilitation, therefore reducing the incidence of
these neuromuscular disorders [26]. The
organizational effort needed to safely perform
physical therapy in ECMO patients needs to be
considered. In our experience the multidisciplinary
team includes two physical therapists, two nurses,
and a physician.
3. Interaction with relatives/friends and medical staff:
patient–relative interactions comprise one of the
most striking differences between the ICU and other
hospital wards. The ability of an awake patient to
communicate with friends and relatives could render
the unfriendly ICU environment a more usual and
easy to cope with situation for both patient and
visitors. Furthermore, it is possible for an awake
patient to communicate her/his symptoms and
needs to the medical staff, something that is heavily
underappreciated and yet is a fundamental source of
information about the patient’s condition and
response to therapy.
Cons
1. Risk of invasive device displacement: awake patients
must be carefully monitored and instructed not to
remove any invasive device to avoid the risk of self-
harm. This is of particular relevance for patients on
ECMO.
2. Patient discomfort, pain and anxiety: an awake
patient requires analgesics for invasive device
tolerance and pain control (e.g., movements during
physiotherapy, invasive procedures). Furthermore,
the ICU can be a very stressful environment because
of the procedures/actions undertaken on the awake
patient as well as those on other patients. Depending
on the organization of the ICU (single room versus
open-plan), supplemental care is required with re-
gard to what is said and done in the proximity of an
awake patient.
Physiology and pathophysiology of the control of
breathing
In normal physiology, spontaneous breathing is largely
controlled by the PCO2 (partial pressure of carbon diox-
ide; and therefore pH) and O2. On one hand, the hypoxic
ventilatory response is activated only at low levels of PO2
(partial pressure of oxygen; 40–50 mmHg) and is, there-
fore, rarely the primary respiratory drive [27]. On the
other hand, the key role of CO2 as a trigger for respiration
has been clearly identified, including through experiments
performed with the use of extracorporeal gas exchange
[28, 29]. Our knowledge on the control of breathing is,
however, largely limited to studies performed on healthy
animals and humans. In conditions of acute lung disease,
lung receptors that are silent in normal physiological con-
ditions might be activated and could play a role in deter-
mining the respiratory pattern of these patients [30].
Interestingly, typical features of lung disease, such as sys-
temic and local pulmonary inflammation [29, 31–33], lung
collapse, and lung microembolism [34], have been shown
to activate these receptors.
Physiology and pathophysiology of spontaneous
breathing
Breathing is a complex function that has the ultimate
purpose of delivering oxygen to every cell of the organism
in order to perform cell respiration, i.e., the production of
energy from the oxidation of a substrate in the presence
of an acceptor of electrons—oxygen. The other purpose of
breathing is the clearance of the waste product of cellular
respiration, namely carbon dioxide.
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Schematically, the respiratory system is composed of a
pump—the respiratory muscles—and a gas exchanger—the
lungs. The pump provides the force needed to expand the
ribcage and lungs, while the coupling between these two
structures is provided by the pleura. During spontaneous
inspiration the ribcage expands and the diaphragm is dis-
placed in the caudal direction. The resultant decrease in
pleural pressure decreases the alveolar pressure to subat-
mospheric levels and, due to this pressure gradient, air
reaches the alveoli through the tracheo-bronchial tree.
Here, gases are passively transferred to and from blood ac-
cording to their partial pressure gradients.
The simplified equation of motion (Eq. 1) describes
the force that must be exerted by the respiratory muscles
in order to move air from the atmosphere to the lungs:
Pmus ¼ V  E þ :V  R ð1Þ
where Pmus represents the pressure exerted by the respira-
tory muscles, E and R the respiratory system elastance
and resistance, respectively, and V and V̇ the volume and
flow, respectively, of gas entering the respiratory system.
During the healthy state, increases in respiratory mus-
cular effort are usually due to increased CO2 production,
e.g., during exercise, with consequently increased venti-
lation (V and V̇) at fairly constant mechanical character-
istics of the lung (E and R). In patients with acute lung
injury, E is typically worsened due to the accumulation
of edema, which causes a reduction in ventilatable lung
volume [11]. Furthermore, airway hyperreactivity and in-
flammation may lead to an increase in R in ARDS pa-
tients [35]. Finally, due to the presence of a high dead
space fraction [36], an increased minute ventilation is
needed in order to remove the metabolically produced
CO2. The combination of these factors results in the
need for greatly increased muscular effort (Pmus) to sat-
isfy the gas exchange needs. Of note, the increased work
of breathing increases oxygen consumption and CO2
production by the respiratory muscles, potentially lead-
ing to a vicious cycle which accelerates the process of
muscular exhaustion.
Available therapeutic options operate on very different
concepts. On the one hand, therapy aims at improving
lung function (E and R) through different pharmaco-
logical interventions, e.g., inhaled bronchodilators or an-
tibiotics. On the other, time is needed for such therapy
to be effective and, therefore, supportive therapy of the
failing respiratory system is required. During controlled
mechanical ventilation the pressure generated by the
ventilator (Pvent) replaces Pmus, therefore acting on the
left side of Eq. 1. This type of intervention has a straight-
forward application during respiratory failure due to
neuromuscular diseases, such as amyotrophic lateral
sclerosis, poliomyelitis, and others, or during general
anesthesia where muscular function is pharmacologically
abolished.
In contrast, vv-ECMO acts on the right side of Eq. 1,
lowering the need to breath (V and V̇), by replacing the
gas exchange function of the lung (CO2 removal and
blood oxygenation). Of note, this type of intervention
would be the logical approach in cases of respiratory
failure due to lung disease, i.e., conditions in which the
respiratory muscles are unaffected by the disease and
the lung function is impaired.
Technical considerations
Cannulation approaches
Venous cannulation for vv-ECMO is preferentially per-
formed percutaneously using the Seldinger technique
[37] and may involve two different approaches: (i) single
site cannulation using bicaval dual-lumen catheters; or
(ii) dual site cannulation (femoro-jugular or femoro-
femoral). Advantages of single site, bicaval dual-lumen
cannulae include freeing up the femoral veins, thus
favoring passive and active physical therapy [38], and re-
duced risk of catheter-related infection and insertion site
bleeding [39]. The catheters used in adults range be-
tween 27 and 31 Fr (9–10.3 mm diameter), i.e., substan-
tially larger diameters are needed compared with dual
site catheters (between 19 and 25 Fr) in order to guaran-
tee sufficient blood flows through the membrane lung
[40]. Positioning bicaval dual-lumen catheters is a major
challenge and fluoroscopy and/or transesophageal echo-
cardiography are usually needed to guarantee the correct
placement [41–43]. Of note, both ventricular rupture
during placement and displacement of the cannula into
the right ventricle or hepatic veins during ECMO support,
with consequent inadequate ECMO blood flow and re-
duced respiratory support, have been described [44, 45].
As cannula displacement could be related to activity/agita-
tion of patients, the use of bicaval dual-lumen cannulae
should be done with caution in potentially agitated pa-
tients or patients with extremely severe respiratory failure.
Due to the complexity and associated risks, patients are
usually anesthetized and intubated for the placement of
bicaval dual-lumen cannulae. In contrast, when using the
dual site approach, cannulation may also be performed in
awake, spontaneously breathing patients under light sed-
ation and local anesthesia. However, at least one cannula
needs to be placed at the groin, i.e., in the femoral vein,
resulting in limited possibility to perform physical therapy.
Physiology of extracorporeal gas exchange and
patient–machine interactions
The physiological rules regulating pulmonary gas ex-
change also apply to extracorporeal gas exchange. Indeed,
CO2removal depends primarily on ventilation of the mem-
brane lung, i.e., on sweep gas flow, and, to a lesser extent,
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on the PCO2 of blood entering the ECMO system. Fur-
thermore, CO2 removal depends, in a logarithmic rela-
tionship, on the blood flow through the membrane
lung [28].
The major determinants of oxygen transfer are the
extracorporeal blood flow and the hemoglobin satur-
ation of blood entering the membrane lung [46], given
that blood oxygenation is a saturable process. Of note,
metabolically produced CO2 (approximately 200 ml/min)
can, in theory, be cleared from a low quantity of venous
blood (0.5–1 L), while significantly higher blood volumes
are required in order to provide an equivalent amount of
oxygen.
The awake, spontaneously breathing patient is an inde-
pendent and unpredictable variable with potentially rele-
vant implications for patient–machine interactions.
Indeed, the maximum blood flow through the ECMO
system depends on not only the size of the cannula, as
mentioned above, but also the adequacy of the central
volume status, i.e., preload and venous return. The vol-
ume status is influenced by heart–lung interactions and,
in spontaneously breathing patients, particularly by the
periodic negative intrathoracic pressures caused by the
activity of the respiratory muscles. During normal,
physiological spontaneous breathing, pleural pressure
swings are small, around 4–6 cmH2O [47] and the
hemodynamic effect is usually negligible. Nevertheless,
during respiratory distress, pleural pressure swings can
increase significantly (often reaching 20–30 cmH2O) and
diaphragmatic excursions can be very pronounced, even
during extracorporeal support (Fig. 2). This, in turn, can
lead to a blood shift from the inferior to the superior
vena cava and to a collapse of the inferior vena cava
caused by increased abdominal pressure. The net result,
in the case of blood drainage from the inferior vena
cava, could be the collapse of the vein around the drain-
age cannula with subsequent reduction in blood flow
(Fig. 3). Of note, bicaval dual-lumen catheters, which
drain from both the intra- and extra-thoracic compart-
ments, should be less affected by this kind of interaction.
Also, blood reinfusion (afterload) can become critical
in the case of increased intrathoracic pressure, such as
during coughing or Valsalva’s maneuver, leading to rele-
vant, though usually transient, reductions in blood flow.
In addition to mechanical patient–machine interactions
linked to blood drainage and reinfusion, physiological and
metabolic interactions caused by extracorporeal gas ex-
change also take place. Extracorporeal CO2 removal, the
primary and most efficient effect of ECMO support, allows
respiratory acidosis to be corrected when present, thus
potentially reducing pulmonary vascular resistance and im-
proving systemic hemodynamics [48]. The respiratory re-
sponse to CO2 removal, initially observed in experimental
studies, is to decrease minute ventilation, up to apnea,
Fig. 2 Esophageal pressure swings during spontaneous breathing in normal conditions and with ARDS. a Esophageal pressure (Pes) trace of an
awake, spontaneously breathing sheep with healthy lungs. Esophageal pressure swings (ΔPes) are around 4–6 cmH2O and the respiratory rate is
around 14–18 breaths per minute. b Pes trace of an awake, spontaneously breathing sheep with oleic acid-induced ARDS. Measured ΔPes values
are around 20–30 cmH2O and respiratory rate is greatly increased. Personal experimental data of Thomas Langer and Andriy Batchinsky [49]
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when 100 % of the metabolically produced CO2 is removed
by the membrane lung [28, 49, 50]. This will reduce the
work of the respiratory muscles, lowering the cost of
breathing, which may be as high as 50 % of total oxygen
consumption in patients with respiratory failure [49, 51].
In clinics, it has been anecdotally observed that some
ECMO patients respond physiologically, i.e., decrease
their alveolar ventilation proportionally to the amount of
CO2 removed extracorporeally, while others tend to vary
their ventilation only slightly with variations of CO2-
removal (manuscript submitted). Reasons for such dif-
ferences are under investigation but hypotheses include
the effect of agitation, discomfort, and cough and the
involvement of mechanisms other than pH/PCO2/PO2
in the control of breathing and dyspnea generation, e.g.,
activation of pulmonary receptors [30, 32, 52].
Of note, hypoventilation induced by extracorporeal CO2
removal will lower the global ventilation-to-perfusion ratio
of the natural lung and could lead to reabsorption atelec-
tasis, therefore worsening hypoxemia [53]. To avoid atel-
ectasis it is useful to (i) titrate sweep gas flow in order to
relieve dyspnea and avoid high pleural pressure swings,
(ii) maintain a certain degree of spontaneous respiratory
activity to avoid hypoventilation-related atelectasis, and
(iii) increase mean airway pressure through the application
of continuous positive airway pressure (CPAP) or non-
invasive ventilation.
Increasing the supply of oxygen through the mem-
brane lung, thus increasing arterial PO2, has a smaller
effect on ventilation compared with CO2 removal, as the
hypoxic respiratory drive is usually involved only at low
PO2 values [27]. Nevertheless, it was demonstrated that
increasing the inspiratory fraction of oxygen and there-
fore PO2 in hypoxic ARDS patients on pressure support
ventilation (leaving all other parameters unchanged)
caused a reduction in minute ventilation, mainly attrib-
utable to a reduced respiratory rate [54].
Finally, vv-ECMO increases venous oxygen saturation
and venous oxygen tension and could, therefore, reduce
hypoxic pulmonary vasoconstriction, having a twofold
effect, (i) increasing the shunt fraction and (ii) reducing
pulmonary arterial pressure, therefore indirectly unload-
ing the right ventricle [55, 56].
Monitoring during awake ECMO
Hemodynamic monitoring in awake, spontaneously
breathing patients on ECMO does not differ from the
monitoring performed in sedated and intubated ECMO
patients. Conversely, respiratory monitoring is a major
challenge. Indeed, physicians are blinded to both airway
pressures and tidal volumes, which are the mainstays of
respiratory monitoring in ventilated patients.
Physicians need, therefore, to rely on the clinical
evaluation of signs and symptoms of respiratory distress,
Fig. 3 Shape of the intra- and extrathoracic veins in different transmural pressure conditions (heart–lung interactions). Changes in pleural
pressure (Ppl), abdominal pressure (Pabd), the shape of the superior and inferior venae cavae (SVC and IVC, respectively), and the amount of blood
flow (arrows) from the abdomen to the thorax during mechanical ventilation (left panel) and spontaneous breathing (right panel). During positive
pressure ventilation, the increased pleural pressure squeezes the SVC and reduces blood flow from the abdominal compartment. This induces a
distention of the IVC, favoring blood drainage to the extracorporeal circuit. During spontaneous breathing with high inspiratory effort, the
significant decrease in pleural pressure dilates the SVC and increases blood flow from the abdominal compartment. This may induce a collapse of
the IVC, hindering blood drainage to the extracorporeal circuit
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such as respiratory rate, dyspnea, rapid shallow breathing,
and others. In addition, some centers monitor esophageal
pressure swings, i.e., a surrogate of variations in pleural
pressure generated by the inspiratory muscles [57]. These
pressure swings are evaluated in dynamic conditions and
represent, therefore, the pressure applied to the alveoli to
overcome both the elastic and resistive workload. The
elastic component is the transpulmonary pressure produ-
cing alveolar inflation, while the resistive component gen-
erates flow through the airways. Of note, both
components, i.e., transpulmonary pressures and negative
inspiratory pressures due to resistive workload, could, in
the case of very high values, worsen the underlying lung
injury [58]. Therefore, from our point of view, and regard-
less of the cause of the increased esophageal swings, these
need to be controlled in order to avoid additional pulmon-
ary injury. Usually, reduction of high esophageal swings
can be achieved by increasing the sweep gas flow, there-
fore increasing extracorporeal CO2 removal. If not suffi-
cient, light sedation could help to slightly reduce the
respiratory drive. At our institution, despite the lack of
sound clinical evidence on the topic, if a patient’s esopha-
geal swings remain “dangerously” high (>15 cmH2O), pa-
tients are usually deeply sedated and switched to
conventional invasive mechanical ventilation.
Evaluation of gas exchange in the native lung
Assessment of gas exchange in the native, diseased
lung is extremely difficult in patients on vv-ECMO.
Proper evaluation of the oxygenation capabilities of
the native lung is hindered by the increased shunt
fraction caused by the partial loss of pulmonary hypoxic
vasoconstriction.
On the other side, evaluation of the CO2clearing cap-
abilities of the native lung is also challenging. At steady
state, CO2 elimination (VCO2) equals CO2 production.
During extracorporeal CO2 removal total VCO2 equals
extracorporeal (VMCO2) plus patient CO2 elimination
(VLCO2). VMCO2 can be easily measured by analyzing
the composition of gas exiting the membrane lung and
multiplying the CO2 concentration by the sweep gas
flow. In contrast, measurement of VLCO2 is difficult in
non-intubated patients. Side-stream capnographs meas-
uring end-tidal CO2 in spontaneously breathing patients
are now available and allow estimation of the alveolar
dead space fraction; however, they do not provide volu-
metric data and VLCO2 cannot, therefore, be assessed.
Of note, the contribution of the membrane lung to gas
exchange can be temporarily zeroed by interruption of
the sweep gas (flow = 0 L/min) so that the performance
of the native lung can be better evaluated. Nevertheless,
this procedure is usually performed during evaluation of
weaning from ECMO and rarely in patients requiring
elevated extracorporeal support.
Clinical pioneering
Bridge to lung transplantation
The use of vv-ECMO in awake, non-intubated spontan-
eously breathing patients was first described for respiratory
deterioration in patients awaiting lung transplantation (as a
“bridge” to lung transplantation). These patients are the
ideal candidates for an awake ECMO approach given their
usual single organ dysfunction, their fragile heart–lung
equilibrium, and the potential great benefit from the main-
tenance of preoperative physical rehabilitation [59, 60].
Several case series have been published over the past years
(Table 1) and, more recently, a retrospective analysis with
historical controls showed a better survival in awake
ECMO patients compared with those on mechanical venti-
lation [61].
Furthermore, a recent study showed that patients
bridged with awake ECMO spent less post-operative
time on mechanical ventilation and had shorter ICU and
hospital lengths of stay compared with patients bridged
with mechanical ventilation [62]. Nonetheless, patients
who experience a rapid respiratory deterioration, and
Table 1 Studies on awake ECMO as a bridge to lung transplantation
Reference Year Number of patients Average bridge duration (days) Type of extracorporeal support Successful bridge
Olsson et al. [72] 2010 5 21 VA 4/5
Fuehner et al. [61] 2012 26 9 VV, VA NA
Javidfar et al. [73] 2012 6 NA VV, VA NA
Hoopes et al. [74] 2013 18 11 VV (10), VA (2) 18/18
PA-LA (2), RA-Ao (4)
Crotti et al. [62] 2013 10 28 VV (8), VA (1), AV (1) 8/10
Lang et al. [75] 2014 5 21 AV (2), VV (2) 5/5
Mohite et al. [76] 2015 7 89 VV, VA NA
Inci et al. [77] 2015 6 NA NA 6/6
Studies on awake ECMO as a bridge to lung transplantation reporting at least five patients are presented in chronological order of publication. “Successful bridge”
defines the number of patients bridged with “awake ECMO” to lung transplantation without the need for intubation and mechanical ventilation
AV arterio-venous, NA not available, PA-LA pulmonary artery-left atrium, RA-Ao right atrium-ascending aorta, VA veno-arterial, VV veno-venous
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therefore need preoperative invasive respiratory support
(mechanical ventilation and/or ECMO), apparently have
a higher postoperative risk of death compared with pa-
tients not requiring preoperative invasive respiratory
support [63]. These findings suggest that the condition
of preoperative patients has a higher impact on postop-
erative outcome than the type of respiratory support.
Exacerbation of chronic obstructive pulmonary disease
Carbon dioxide retention, caused by dynamic hyperinfla-
tion, ventilation/perfusion mismatch, and reduction of al-
veolar ventilation, is a typical feature of acute exacerbation
of chronic obstructive pulmonary disease (COPD). In the
case of failed medical therapy and non-invasive ventilation,
intubation and invasive mechanical ventilation might be-
come necessary [64], exposing these patients to several
mechanical ventilation-associated side effects.
Since COPD patients are usually characterized by hyper-
capnia and only mild hypoxemia, low blood flow extracor-
poreal CO2 removal systems could be sufficient to unload
their respiratory system. Pioneering studies on the topic de-
scribed a reduced intubation rate in acute exacerbations of
COPD patients failing non-invasive ventilation and sup-
ported with extracorporeal gas exchange (Table 2) [65–68].
Furthermore, some authors described the possibility,
through the use of extracorporeal CO2 removal, to facilitate
extubation and perform physical therapy in COPD patients
already supported with mechanical ventilation [65, 69].
Despite the lack of sound clinical evidence, this strategy
seems to be promising given the known drawbacks of
mechanical ventilation in this category of patients.
Acute respiratory distress syndrome
Recently, some groups have explored the possibility of
using ECMO as an alternative to mechanical ventilation
also in awake, spontaneously breathing ARDS patients
[70, 71]. Available data are very scarce; nevertheless, pa-
tients of this sort with respiratory failure appear to be
more complicated to treat with an awake ECMO ap-
proach given their frequent multiple organ dysfunction.
Conclusions
There is a strong rationale for the use of vv-ECMO in
the treatment of respiratory failure in awake, spontan-
eously breathing patients (awake ECMO) as it allows
several side effects related to sedation, intubation, and
mechanical ventilation to be avoided. However, the com-
plexity of the heart–lung–ECMO system interactions
and the difficulties related to respiratory monitoring and
the management of an awake patient on extracorporeal
support make the awake ECMO patient a major chal-
lenge for the ICU staff. At the time of writing, sound
clinical data on the topic are scarce and future clinical
studies are needed in order to improve our understand-
ing of the pathophysiology of awake ECMO patients and
to evaluate any possible outcome benefit compared with
the current standard of care.
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Table 2 Studies on awake ECMO in COPD and ARDS patients
Reference Year Type of
disease
Number of
patients
Average support
duration (days)
Type of extracorporeal
support
Successful management
without IMV
Successful weaning
from IMV
Kluge et al.
[68]
2012 COPD 14 9 PECLA 13/14 NA
Burki et al.
[66]
2013 COPD 20 4 Low flow ECCO2R 9/9
* 3/11§
Abrams et al.
[65]
2013 COPD 5 8 Low flow ECCO2R NA 5
Del Sorbo et
al. [67]
2015 COPD 25 2 Low flow ECCO2R 22/25 NA
Hoeper et al.
[70]
2013 ARDS 6 10 VV 3/6 NA
Studies on awake ECMO for acute exacerbation of COPD or ARDS reporting at least five patients are presented in chronological order of publication and
according to type of disease. “Successful management without IMV” defines the number of patients managed without invasive mechanical ventilation during the
ICU stay. “Successful weaning from IMV” defines the number of patients already intubated, mechanically ventilated, and on ECMO who were weaned from
invasive mechanical ventilation, extubated, and managed with awake ECMO. *Patients of groups 1 and 2 and §patients of group 3 of the original publication by
Burki et al.
ARDS acute respiratory distress syndrome, COPD chronic obstructive pulmonary disease, ECCO2R extra-corporeal CO2 removal, IMV invasive mechanical ventilation,
NA not available, PECLA pumpless extra-corporal lung assist; VV veno-venous
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